T. Taube

837 total citations
15 papers, 620 citations indexed

About

T. Taube is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Orthopedics and Sports Medicine. According to data from OpenAlex, T. Taube has authored 15 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in T. Taube's work include Bone health and treatments (13 papers), Prostate Cancer Treatment and Research (5 papers) and Bone health and osteoporosis research (5 papers). T. Taube is often cited by papers focused on Bone health and treatments (13 papers), Prostate Cancer Treatment and Research (5 papers) and Bone health and osteoporosis research (5 papers). T. Taube collaborates with scholars based in Finland, United Kingdom and France. T. Taube's co-authors include John А. Kanis, Inkeri Elomaa, M.N.C. Benéton, Carl Blomqvist, Timo Kylmälä, M. Greaves, E. V. McCloskey, Susan Rogers, Leila Risteli and Juha Risteli and has published in prestigious journals such as British Journal of Cancer, European Urology and European Journal of Cancer.

In The Last Decade

T. Taube

15 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Taube Finland	12	515	201	162	146	128	15	620
Richard Leff United States	9	529 1.0×	228 1.1×	190 1.2×	95 0.7×	52 0.4×	14	659
A Fontana France	10	324 0.6×	106 0.5×	89 0.5×	78 0.5×	133 1.0×	25	505
Frank M. Senecal United States	7	626 1.2×	109 0.5×	94 0.6×	119 0.8×	47 0.4×	9	743
Bijvoet Ol Netherlands	10	515 1.0×	128 0.6×	150 0.9×	20 0.1×	171 1.3×	17	720
Narciso Hernández Toriz Mexico	4	596 1.2×	168 0.8×	353 2.2×	21 0.1×	204 1.6×	6	799
A. Galid Austria	9	519 1.0×	155 0.8×	167 1.0×	56 0.4×	96 0.8×	27	748
Lea Latham Italy	9	163 0.3×	59 0.3×	173 1.1×	36 0.2×	113 0.9×	17	401
Amy Kupic United States	3	603 1.2×	175 0.9×	347 2.1×	19 0.1×	197 1.5×	5	798
W. Dornoff Germany	9	569 1.1×	202 1.0×	259 1.6×	13 0.1×	71 0.6×	15	688
J.L. Chin Canada	6	751 1.5×	384 1.9×	583 3.6×	40 0.3×	78 0.6×	8	966

Countries citing papers authored by T. Taube

Since Specialization

Citations

This map shows the geographic impact of T. Taube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Taube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Taube more than expected).

Fields of papers citing papers by T. Taube

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Taube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Taube. The network helps show where T. Taube may publish in the future.

Co-authorship network of co-authors of T. Taube

This figure shows the co-authorship network connecting the top 25 collaborators of T. Taube. A scholar is included among the top collaborators of T. Taube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Taube. T. Taube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Saarto, Tiina, T. Taube, Carl Blomqvist, Leena Vehmanen, & Inkeri Elomaa. (2005). Three-Year Oral Clodronate Treatment Does Not Impair Mineralization of Newly Formed Bone—A Histomorphometric Study. Calcified Tissue International. 77(2). 84–90. 6 indexed citations

McCloskey, Eugène, T. Taube, Robert M. Cox, et al.. (2000). Metacarpal Morphometry Using a Semi-automated Technique in the Assessment of Osteoporosis and Vertebral Fracture Risk. Osteoporosis International. 11(11). 953–958. 23 indexed citations

Laitinen, Kalevi & T. Taube. (1999). Clodronate as a Cause of Aminotransferase Elevation. Osteoporosis International. 10(2). 120–122. 13 indexed citations

Kylmälä, Timo, et al.. (1997). Concomitant i.v. and oral clodronate in the relief of bone pain – a double-blind placebo-controlled study in patients with prostate cancer. British Journal of Cancer. 76(7). 939–942. 72 indexed citations

Taube, T., Timo Kylmälä, Christel Lamberg‐Allardt, Teuvo L.J. Tammela, & Inkeri Elomaa. (1994). The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study. European Journal of Cancer. 30(6). 751–758. 33 indexed citations

Taube, T., Inkeri Elomaa, Carl Blomqvist, M.N.C. Benéton, & John А. Kanis. (1994). Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone. 15(2). 161–166. 132 indexed citations

Taube, T., M.N.C. Benéton, Jessica Williams, Eugène McCloskey, & J. A. Kanis. (1993). Distinction between Focally Accelerated Bone Formation and Osteomalacia in Carcinoma of Prostate Metastasised to Bone. British Journal of Urology. 72(1). 98–103. 12 indexed citations

Kylmälä, Timo, Teuvo L.J. Tammela, Leila Risteli, et al.. (1993). Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group. European Journal of Cancer. 29(6). 821–825. 59 indexed citations

Taube, T., Inkeri Elomaa, Carl Blomqvist, M.N.C. Benéton, & John А. Kanis. (1993). Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: A histomorphometric study. European Journal of Cancer. 29(12). 1677–1681. 21 indexed citations

10.

Taube, T., et al.. (1992). Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP). British Journal of Haematology. 82(1). 32–37. 13 indexed citations

11.

Taube, T., M.N.C. Benéton, E. V. McCloskey, et al.. (1992). Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. European Journal Of Haematology. 49(4). 192–198. 154 indexed citations

12.

Taube, T., Inkeri Elomaa, Carl Blomqvist, M.N.C. Benéton, & John А. Kanis. (1992). Effects of clodronate and calcitonin on bone resorption in metastatic breast cancer. Bone and Mineral. 17. S28–S28. 1 indexed citations

13.

Kanis, John А., et al.. (1991). Rationale for the use of bisphosphonates in bone metastases. Bone. 12. S13–S18. 38 indexed citations

14.

Elomaa, Inkeri, T. Taube, Carl Blomqvist, et al.. (1988). Aminoglutethimide for Advanced Prostatic Cancer Resistant toConventional Hormonal Therapy. European Urology. 14(2). 104–106. 5 indexed citations

15.

Elomaa, Inkeri, Carl Blomqvist, L. Porkka, et al.. (1988). Clodronate for osteolytic metastases due to breast cancer.. PubMed. 42(2). 111–6. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact